OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Renal Cell Carcinoma
Tracy L. Rose, William Y. Kim
JAMA (2024) Vol. 332, Iss. 12, pp. 1001-1001
Closed Access | Times Cited: 18
Tracy L. Rose, William Y. Kim
JAMA (2024) Vol. 332, Iss. 12, pp. 1001-1001
Closed Access | Times Cited: 18
Showing 18 citing articles:
Contribution and expression of renal drug transporters in renal cell carcinoma
Yufang Zuo, Tong Li, Shilei Yang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 2
Yufang Zuo, Tong Li, Shilei Yang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 2
Genetic Variations in MDM2 Gene Contribute to Renal Cell Carcinoma Susceptibility: A Genotype–Phenotype Correlation Study
Shu-Yu Chang, WEN-SHIN CHANG, Hou-Yu Shih, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 177-177
Open Access
Shu-Yu Chang, WEN-SHIN CHANG, Hou-Yu Shih, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 177-177
Open Access
Pharmacovigilance imbalance analysis of VEGFR-TKI-related taste and smell disorders
Zhonghua Fu, Chenglong Zhao, Yaqin Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Zhonghua Fu, Chenglong Zhao, Yaqin Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Robotic Surgery in the Management of Renal Tumors During Pregnancy: A Narrative Review
Lucio Dell’Atti, Viktoria Slyusar
Cancers (2025) Vol. 17, Iss. 4, pp. 574-574
Open Access
Lucio Dell’Atti, Viktoria Slyusar
Cancers (2025) Vol. 17, Iss. 4, pp. 574-574
Open Access
CNPY2 in Solid Tumors: Mechanisms, Biomarker Potential, and Therapeutic Implications
Sayan Mullick Chowdhury, Feng Hong, Christian Rolfo, et al.
Biology (2025) Vol. 14, Iss. 2, pp. 214-214
Open Access
Sayan Mullick Chowdhury, Feng Hong, Christian Rolfo, et al.
Biology (2025) Vol. 14, Iss. 2, pp. 214-214
Open Access
Targeting Heat Shock Transcription Factor 4 Enhances the Efficacy of Cabozantinib and Immune Checkpoint Inhibitors in Renal Cell Carcinoma
Saeki Saito, Hirofumi Yoshino, Seiya Yokoyama, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1776-1776
Open Access
Saeki Saito, Hirofumi Yoshino, Seiya Yokoyama, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1776-1776
Open Access
Incidence and survival patterns of clear cell renal cell carcinoma from 2000 to 2017: A SEER Database Analysis
Sijue Zou, Liwen Cui, Pearl Pai, et al.
Journal of Cancer (2025) Vol. 16, Iss. 5, pp. 1591-1597
Open Access
Sijue Zou, Liwen Cui, Pearl Pai, et al.
Journal of Cancer (2025) Vol. 16, Iss. 5, pp. 1591-1597
Open Access
Unveiling the multifaceted roles of long non-coding RNA CTBP1-DT in human diseases: Special attention to its microprotein-encoding potential
Jingjie Yang
Pathology - Research and Practice (2025) Vol. 268, pp. 155870-155870
Closed Access
Jingjie Yang
Pathology - Research and Practice (2025) Vol. 268, pp. 155870-155870
Closed Access
Association of 5α-reductase inhibitor prescription with immunotherapy efficacy in metastatic renal cell carcinoma: a multicenter retrospective analysis
Bisheng Cheng, Jilin Wu, Ke Chen, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e011154-e011154
Open Access
Bisheng Cheng, Jilin Wu, Ke Chen, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e011154-e011154
Open Access
BUB1-deficiency suppresses kidney renal clear cell carcinoma progression via the PI3K/Akt pathway: A bioinformatics-oriented validating study
Xiaolin Zi, Jinpeng Ma, Xiaoxia Li, et al.
Molecular and Cellular Probes (2025), pp. 102024-102024
Open Access
Xiaolin Zi, Jinpeng Ma, Xiaoxia Li, et al.
Molecular and Cellular Probes (2025), pp. 102024-102024
Open Access
Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: a European multicenter study (LENVA-LAT)
Javier Gavira, Édouard Auclin, Macarena Rey-Cardenas, et al.
European Journal of Cancer (2025) Vol. 220, pp. 115389-115389
Closed Access
Javier Gavira, Édouard Auclin, Macarena Rey-Cardenas, et al.
European Journal of Cancer (2025) Vol. 220, pp. 115389-115389
Closed Access
Robot-assisted partial nephrectomy and robot-assisted radical prostatectomy using the Chinese surgical systems KangDuo-SR-2000 and EDGE MP1000 versus the Da Vinci Xi system: a prospective, single-center, non-randomized clinical trial
Pengyu Guo, Honglei Wang, Zixing Wang, et al.
World Journal of Urology (2025) Vol. 43, Iss. 1
Closed Access
Pengyu Guo, Honglei Wang, Zixing Wang, et al.
World Journal of Urology (2025) Vol. 43, Iss. 1
Closed Access
2‐Undecanone induces ferroptosis via the STAT3 /GPX4 pathway to enhance sensitivity of renal cell carcinoma to sunitinib
Zixuan Chen, Chengtao Han, Huiwen Xie, et al.
BioFactors (2025) Vol. 51, Iss. 2
Closed Access
Zixuan Chen, Chengtao Han, Huiwen Xie, et al.
BioFactors (2025) Vol. 51, Iss. 2
Closed Access
Tumor-Educated Platelets in Urological Tumors: A Novel Biosource in Liquid Biopsy
Mariona Figols, Sviatoslav Chekhun, Maria Fernández-Saorin, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3595-3595
Open Access
Mariona Figols, Sviatoslav Chekhun, Maria Fernández-Saorin, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3595-3595
Open Access
Comparison of active surveillance vs. partial nephrectomy results in small renal masses
Yusuf Arıkan, Serhat Beyan, Cemre Kuscuoglu, et al.
Mini-invasive Surgery (2025)
Open Access
Yusuf Arıkan, Serhat Beyan, Cemre Kuscuoglu, et al.
Mini-invasive Surgery (2025)
Open Access
Impact of Mannitol Administration on Postoperative Renal Function After Robot-Assisted Partial Nephrectomy
Kazuki Taniguchi, Tomoki Taniguchi, Kentaro Muraoka, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6444-6444
Open Access
Kazuki Taniguchi, Tomoki Taniguchi, Kentaro Muraoka, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6444-6444
Open Access
Centromere protein K enhances the activation of YAP1/TAZ signal cascade to drive the progression of clear cell renal cell carcinoma
Ning Nan
Toxicology and Applied Pharmacology (2024), pp. 117181-117181
Closed Access
Ning Nan
Toxicology and Applied Pharmacology (2024), pp. 117181-117181
Closed Access
Real-World Oncological Outcomes of Nivolumab Plus Ipilimumab in Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study in Japan
Tomoki Taniguchi, Koji Iinuma, Kei Kawada, et al.
Current Oncology (2024) Vol. 31, Iss. 12, pp. 7914-7923
Open Access
Tomoki Taniguchi, Koji Iinuma, Kei Kawada, et al.
Current Oncology (2024) Vol. 31, Iss. 12, pp. 7914-7923
Open Access
Clinical value of contrast-enhanced ultrasound combined with quantitative analysis in Bosniak ≥ II cystic renal masses
Huabin He, Xuanchen Jin, Yuncai Liu, et al.
Abdominal Radiology (2024)
Closed Access
Huabin He, Xuanchen Jin, Yuncai Liu, et al.
Abdominal Radiology (2024)
Closed Access
Gemcitabine-Loaded Microbeads for Transarterial Chemoembolization of Rabbit Renal Tumor Monitored by 18F-FDG Positron Emission Tomography/X-Ray Computed Tomography Imaging
Xiaoli Zhang, Tingting Li, Jindong Tong, et al.
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1609-1609
Open Access
Xiaoli Zhang, Tingting Li, Jindong Tong, et al.
Pharmaceutics (2024) Vol. 16, Iss. 12, pp. 1609-1609
Open Access
